Medicare Enrolled
Dr. Bruce Mayerson, MD
Neurology · Smithtown, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mayerson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mayerson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mayerson
Dr. Bruce Mayerson is a neurology specialist in Smithtown, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mayerson performed 2,551 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mayerson received a total of $5,555 from 41 pharmaceutical and/or device companies across 258 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mayerson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 17% volume in NY
$5,555 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,551
Medicare services
Top 17% in NY for neurology
Not available
Unique patients (not deduplicated)
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
616 | $110 | $437 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
562 | $74 | $270 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
188 | $222 | $827 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
171 | $111 | $406 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $139 | $560 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
132 | $93 | $341 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
104 | $158 | $599 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
101 | $12 | $46 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
88 | $116 | $447 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
58 | $209 | $968 |
| Ultrasound of brain blood flow following medication An ultrasound test used to assess blood flow within the brain after a medication has been administered. |
58 | $216 | $994 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
58 | $159 | $1,139 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
51 | $60 | $219 |
| New patient office visit, complex (60-74 min) | 49 | $186 | $764 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
43 | $234 | $855 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
29 | $270 | $986 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
27 | $200 | $731 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $45 | $173 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $162 | $591 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
16 | $105 | $437 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
14 | $198 | $735 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,555
Total received (2018-2024)
Avg $794/year across 7 years
Top 31% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
258
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,130
2023
$1,322
2022
$929
2021
$554
2020
$311
2019
$235
2018
$74
Payments by company (2024)
ABBVIE INC.
$547
UCB, Inc.
$169
Neurocrine Biosciences, Inc.
$166
Abbott Laboratories
$143
Lilly USA, LLC
$124
SK Life Science, Inc.
$98
Biogen, Inc.
$96
ACADIA Pharmaceuticals Inc
$90
Celgene Corporation
$89
Acorda Therapeutics, Inc
$86
Lundbeck LLC
$76
Vanda Pharmaceuticals Inc.
$75
Grifols USA, LLC
$69
Otsuka America Pharmaceutical, Inc.
$69
Amneal Pharmaceuticals LLC
$42
PFIZER INC.
$37
Philips North America LLC
$33
ARGENX US, INC.
$30
Kyowa Kirin, Inc.
$25
MITSUBISHI TANABE PHARMA AMERICA, INC.
$25
MDD US Operations, LLC
$24
Novartis Pharmaceuticals Corporation
$17
Top 3 companies account for 41.4% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,138
Celgene Corporation
$367
Acorda Therapeutics, Inc
$312
Neurocrine Biosciences, Inc.
$277
Biogen, Inc.
$263
SK Life Science, Inc.
$251
UCB, Inc.
$247
Lilly USA, LLC
$225
Eisai Inc.
$215
Sunovion Pharmaceuticals Inc.
$211
ACADIA Pharmaceuticals Inc
$192
PFIZER INC.
$180
Lundbeck LLC
$145
Abbott Laboratories
$143
Grifols USA, LLC
$122
GENZYME CORPORATION
$97
Braemar Manufacturing, LLC
$93
Allergan, Inc.
$87
Medtronic Vascular, Inc.
$86
Vanda Pharmaceuticals Inc.
$75
MITSUBISHI TANABE PHARMA AMERICA, INC.
$71
AbbVie Inc.
$71
Otsuka America Pharmaceutical, Inc.
$69
Biohaven Pharmaceutical Holding Company Ltd.
$68
AstraZeneca Pharmaceuticals LP
$68
Amneal Pharmaceuticals LLC
$62
EISAI INC.
$61
Kyowa Kirin, Inc.
$42
Supernus Pharmaceuticals, Inc.
$36
Philips North America LLC
$33
ARGENX US, INC.
$30
Allergan Inc.
$28
EMD Serono, Inc.
$26
MDD US Operations, LLC
$24
IMPEL PHARMACEUTICALS INC.
$23
Genentech USA, Inc.
$23
Avanir Pharmaceuticals, Inc.
$22
Medtronic, Inc.
$21
Novartis Pharmaceuticals Corporation
$17
Avion Pharmaceuticals
$17
Adamas Pharmaceuticals, Inc.
$15
Top 3 companies account for 32.7% of all-time payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · ADUHELM · AMPLATZER TALISMAN · AMYVID · ANDEXXA · APTIOM · AUBAGIO · Aduhelm · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · CREXONT · Cardiac Monitoring Suite · Dhivy · EMGALITY · GOCOVRI · Gamunex-C · Gocovri · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LINQ II · Leqembi · MAVENCLAD · NOURIANZ · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · Ongentys · PONVORY · QULIPTA · RADICAVA · REXULTI · RYTARY · Reveal LINQ · Rystiggo · Trudhesa · UBRELVY · VUMERITY · VYEPTI · VYVGART · Xembify · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
205
County median income
$128,329
Nearest hospital to ZIP centroid (approximate)
ST CATHERINE OF SIENA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mayerson is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mayerson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mayerson performed 616 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mayerson receive payments from pharmaceutical companies?
Yes. Dr. Mayerson received a total of $5,555 from 41 companies across 258 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mayerson's costs compare to other neurologists in Smithtown?
Dr. Mayerson's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mayerson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Smithtown
Browse neurologists in Smithtown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Acorda Therapeutics, Inc Payments to Doctors
See all physicians who received payments from Acorda Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology